ENvue Medical (FEED) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.29% |
| Dec 31, 2025 | -56.79% |
| Sep 30, 2025 | 46.15% |
| Jun 30, 2025 | -51.80% |
| Mar 31, 2025 | 130.86% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | -53.98% |
| Jun 30, 2024 | -11.29% |
| Mar 31, 2024 | -21.75% |
| Dec 31, 2023 | 156.99% |
| Sep 30, 2023 | 55.78% |
| Jun 30, 2023 | -16.95% |
| Mar 31, 2023 | 447.06% |
| Dec 31, 2022 | -205.15% |
| Sep 30, 2022 | -80.00% |
| Jun 30, 2022 | 78.31% |
| Mar 31, 2022 | -64.90% |
| Dec 31, 2021 | 55.31% |
| Sep 30, 2021 | 56.92% |
| Jun 30, 2021 | 208.74% |
| Mar 31, 2021 | 14.44% |
| Dec 31, 2020 | -40.00% |
| Sep 30, 2020 | -44.24% |
| Jun 30, 2020 | 135.96% |
| Mar 31, 2020 | 31.03% |
| Dec 31, 2019 | -13.86% |
| Sep 30, 2019 | -61.60% |
| Jun 30, 2019 | 232.91% |
| Mar 31, 2019 | 46.30% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | -59.09% |
| Jun 30, 2018 | 71.43% |
| Mar 31, 2018 | 10.00% |
| Dec 31, 2017 | 7.69% |
| Sep 30, 2017 | 25.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 6.12% |
| Dec 31, 2016 | -19.67% |
| Sep 30, 2016 | -1.61% |
| Jun 30, 2016 | 8.77% |
| Mar 31, 2016 | 46.15% |
| Dec 31, 2015 | -2.50% |
| Sep 30, 2015 | 2.56% |
| Jun 30, 2015 | 34.48% |
| Mar 31, 2015 | -44.23% |
| Dec 31, 2014 | 108.00% |
| Sep 30, 2014 | -60.94% |
| Jun 30, 2014 | 3.23% |